Bio-Techne Corp. buy UBS Group AG
Start price
05.02.26
/
50%
€56.00
Target price
05.02.27
-
Performance (%)
11.82%
Price
30.07.26
€62.46
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG currently has a performance of 11.82%. Dividends of €0.16 are taken into consideration when calculating the performance. This prediction currently runs until 05.02.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Bio-Techne Corp. | -0.983% | -0.983% |
| iShares Core DAX® | 2,59 % | 2,69 % |
| iShares Nasdaq 100 | -0,91 % | -7,37 % |
| iShares Nikkei 225® | 0,15 % | -10,20 % |
| iShares S&P 500 | -0,37 % | -0,83 % |
Comments by UBS_Group_AG for this prediction
In the thread Bio-Techne Corp. diskutieren
Bio-Techne (NASDAQ:TECH) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Ratings data for TECH provided by MarketBeat